Menu
Ariel’s targeted next-generation DNA sequencing (NGS) uses ADVANCE®, a cutting-edge technology that enables high-throughput and rapid results for clinical and research applications. ADVANCE utilizes some of the most advanced insights into systems biology, evidence-based medicine, genetic linkages and domain expertise to provide a thorough interpretation of targeted genetic regions associated with chronic digestive diseases. Genes available for sequencing include those on our clinical panels plus numerous additional targets. Please contact Ariel to determine if your regions of interest are covered.
Ariel Precision Medicine’s multidisciplinary team of physicians, computer scientists, biologists, and bioinformaticians can custom analyze client biological data generated from a wide variety of genotyping and sequencing platforms. Equipped with the latest state-of-the-art computing tools and software, our team offers custom bioinformatics services per each customer’s needs.